<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35204833</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>Butyrate Ameliorates Mitochondrial Respiratory Capacity of The Motor-Neuron-like Cell Line NSC34-G93A, a Cellular Model for ALS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">333</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom12020333</ELocationID><Abstract><AbstractText>Mitochondrial defects in motor neurons are pathological hallmarks of ALS, a neuromuscular disease with no effective treatment. Studies have shown that butyrate, a natural gut-bacteria product, alleviates the disease progression of ALS mice overexpressing a human ALS-associated mutation, hSOD1<sup>G93A</sup>. In the current study, we examined the potential molecular mechanisms underlying the effect of butyrate on mitochondrial function in cultured motor-neuron-like NSC34 with overexpression of hSOD1<sup>G93A</sup> (NSC34-G93A). The live cell confocal imaging study demonstrated that 1mM butyrate in the culture medium improved the mitochondrial network with reduced fragmentation in NSC34-G93A cells. Seahorse analysis revealed that NSC34-G93A cells treated with butyrate showed an increase of ~5-fold in mitochondrial Spare Respiratory Capacity with elevated Maximal Respiration. The time-dependent changes in the mRNA level of PGC1&#x3b1;, a master regulator of mitochondrial biogenesis, revealed a burst induction with an early increase (~5-fold) at 4 h, a peak at 24 h (~19-fold), and maintenance at 48 h (8-fold) post-treatment. In line with the transcriptional induction of PGC1&#x3b1;, both the mRNA and protein levels of the key molecules (MTCO1, MTCO2, and COX4) related to the mitochondrial electron transport chain were increased following the butyrate treatment. Our data indicate that activation of the PGC1&#x3b1; signaling axis could be one of the molecular mechanisms underlying the beneficial effects of butyrate treatment in improving mitochondrial bioenergetics in NSC34-G93A cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xuejun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Kinesiology, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76019, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bone-Muscle Research Center, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76019, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Kinesiology, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76019, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bone-Muscle Research Center, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76019, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ang</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8784-4702</Identifier><AffiliationInfo><Affiliation>Department of Kinesiology, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76019, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bone-Muscle Research Center, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76019, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Jianxun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Kinesiology, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76019, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bone-Muscle Research Center, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76019, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brotto</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bone-Muscle Research Center, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76019, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jingsong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Kinesiology, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76019, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bone-Muscle Research Center, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76019, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL138570</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS105621</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002087">Butyrates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071248">Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002087" MajorTopicYN="N">Butyrates</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071248" MajorTopicYN="N">Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">NSC34 cell line</Keyword><Keyword MajorTopicYN="N">PGC1&#x3b1;</Keyword><Keyword MajorTopicYN="N">butyrate</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>25</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35204833</ArticleId><ArticleId IdType="pmc">PMC8869540</ArticleId><ArticleId IdType="doi">10.3390/biom12020333</ArticleId><ArticleId IdType="pii">biom12020333</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhang Y., Ogbu D., Garrett S., Xia Y., Sun J. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis. Gut Microbes. 2021;13:1996848. doi: 10.1080/19490976.2021.1996848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.1996848</ArticleId><ArticleId IdType="pmc">PMC8632307</ArticleId><ArticleId IdType="pubmed">34812107</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.-G., Wu S., Yi J., Xia Y., Jin D., Zhou J., Sun J. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin. Ther. 2017;39:322&#x2013;336. doi: 10.1016/j.clinthera.2016.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2016.12.014</ArticleId><ArticleId IdType="pmc">PMC5344195</ArticleId><ArticleId IdType="pubmed">28129947</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A., Logroscino G., Jick S., Hern&#xe1;n M. Incidence and lifetime risk of motor neuron disease in the United Kingdom: A population-based study. Eur. J. Neurol. 2009;16:745&#x2013;751. doi: 10.1111/j.1468-1331.2009.02586.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02586.x</ArticleId><ArticleId IdType="pmc">PMC3093130</ArticleId><ArticleId IdType="pubmed">19475756</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Brown R.H. Molecular biology of amyotrophic lateral sclerosis: Insights from genetics. Nat. Rev. Neurosci. 2006;7:710&#x2013;723. doi: 10.1038/nrn1971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1971</ArticleId><ArticleId IdType="pubmed">16924260</ArticleId></ArticleIdList></Reference><Reference><Citation>Engl E., Attwell D. Non-signalling energy use in the brain. J. Physiol. 2015;593:3417&#x2013;3429. doi: 10.1113/jphysiol.2014.282517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2014.282517</ArticleId><ArticleId IdType="pmc">PMC4560575</ArticleId><ArticleId IdType="pubmed">25639777</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.F., Shaw P., De Vos K.J. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr&#xec; M.T., D&#x2019;Ambrosi N., Cozzolino M. Pathways to mitochondrial dysfunction in ALS pathogenesis. Biochem. Biophys. Res. Commun. 2017;483:1187&#x2013;1193. doi: 10.1016/j.bbrc.2016.07.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.07.055</ArticleId><ArticleId IdType="pubmed">27416757</ArticleId></ArticleIdList></Reference><Reference><Citation>Echaniz-Laguna A., Zoll J., Ponsot E., N&#x2019;Guessan B., Tranchant C., Loeffler J.-P., Lampert E. Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: A temporal study in man. Exp. Neurol. 2006;198:25&#x2013;30. doi: 10.1016/j.expneurol.2005.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2005.07.020</ArticleId><ArticleId IdType="pubmed">16126198</ArticleId></ArticleIdList></Reference><Reference><Citation>Napoli L., Crugnola V., Lamperti C., Silani V., Di Mauro S., Bresolin N., Moggio M. Ultrastructural mitochondrial abnormalities in patients with sporadic amyotrophic lateral sclerosis. Arch. Neurol. 2011;68:1612&#x2013;1613. doi: 10.1001/archneur.68.12.1612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.68.12.1612</ArticleId><ArticleId IdType="pubmed">22159065</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Iwata M. Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2007;66:10&#x2013;16. doi: 10.1097/nen.0b013e31802c396b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e31802c396b</ArticleId><ArticleId IdType="pubmed">17204932</ArticleId></ArticleIdList></Reference><Reference><Citation>Siciliano G., Pastorini E., Pasquali L., Manca M.L., Iudice A., Murri L. Impaired oxidative metabolism in exercising muscle from ALS patients. J. Neurol. Sci. 2001;191:61&#x2013;65. doi: 10.1016/S0022-510X(01)00620-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00620-7</ArticleId><ArticleId IdType="pubmed">11676993</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorar&#xf9; G., Vergani L., Fedrizzi L., D&#x2019;Ascenzo C., Polo A., Bernazzi B., Angelini C. Activities of mitochondrial complexes correlate with nNOS amount in muscle from ALS patients. Neuropathol. Appl. Neurobiol. 2007;33:204&#x2013;211. doi: 10.1111/j.1365-2990.2006.00791.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2006.00791.x</ArticleId><ArticleId IdType="pubmed">17359361</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann F.R., Manfredi G., Mawrin C., Beal M.F., Schon E.A. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J. Neurochem. 2002;80:616&#x2013;625. doi: 10.1046/j.0022-3042.2001.00731.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0022-3042.2001.00731.x</ArticleId><ArticleId IdType="pubmed">11841569</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr&#xec; M.T., Cozzolino M. SOD1 and mitochondria in ALS: A dangerous liaison. J. Bioenerg. Biomembr. 2011;43:593&#x2013;599. doi: 10.1007/s10863-011-9394-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10863-011-9394-z</ArticleId><ArticleId IdType="pubmed">22081209</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino M., Ferri A., Valle C., Carr&#xec; M.T. Mitochondria and ALS: Implications from novel genes and pathways. Mol. Cell. Neurosci. 2013;55:44&#x2013;49. doi: 10.1016/j.mcn.2012.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2012.06.001</ArticleId><ArticleId IdType="pubmed">22705710</ArticleId></ArticleIdList></Reference><Reference><Citation>Federico A., Cardaioli E., Da Pozzo P., Formichi P., Gallus G.N., Radi E. Mitochondria, oxidative stress and neurodegeneration. J. Neurol. Sci. 2012;322:254&#x2013;262. doi: 10.1016/j.jns.2012.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2012.05.030</ArticleId><ArticleId IdType="pubmed">22669122</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanova M.I., Sievers S.A., Guenther E.L., Johnson L.M., Winkler D.D., Galaleldeen A., Sawaya M.R., Hart P.J., Eisenberg D.S. Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALS. Proc. Natl. Acad. Sci. USA. 2014;111:197&#x2013;201. doi: 10.1073/pnas.1320786110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1320786110</ArticleId><ArticleId IdType="pmc">PMC3890817</ArticleId><ArticleId IdType="pubmed">24344300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A.C., Bendotti C., Blaugrund E., Chio A., Greensmith L., Loeffler J.-P., Mead R., Niessen H.G., Petri S., Pradat P.-F., et al. Guidelines for preclinical animal research in ALS/MND: A consensus meeting. Amyotroph. Lateral Scler. 2010;11:38&#x2013;45. doi: 10.3109/17482960903545334.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903545334</ArticleId><ArticleId IdType="pubmed">20184514</ArticleId></ArticleIdList></Reference><Reference><Citation>McGoldrick P., Joyce P.I., Fisher E., Greensmith L. Rodent models of amyotrophic lateral sclerosis. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 2013;1832:1421&#x2013;1436. doi: 10.1016/j.bbadis.2013.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2013.03.012</ArticleId><ArticleId IdType="pubmed">23524377</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.-X., Shi Y., Furukawa Y., Zhai H., Fu R., Liu E., Gorrie G.H., Khan M.S., Hung W.-Y., Bigio E.H., et al. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc. Natl. Acad. Sci. USA. 2006;103:7142&#x2013;7147. doi: 10.1073/pnas.0602046103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0602046103</ArticleId><ArticleId IdType="pmc">PMC1447523</ArticleId><ArticleId IdType="pubmed">16636275</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins C.M.J., Jung C.W., Ding H.L., Xu Z.S. Mutant Cu, Zn superoxide dismutase that causes motoneu-ron degeneration is present in mitochondria in the CNS. J. Neurosci. 2002;22:RC215. doi: 10.1523/JNEUROSCI.22-06-j0001.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-06-j0001.2002</ArticleId><ArticleId IdType="pmc">PMC6758252</ArticleId><ArticleId IdType="pubmed">11886899</ArticleId></ArticleIdList></Reference><Reference><Citation>Igoudjil A., Magran&#xe9; J., Fischer L.R., Kim H.J., Hervias I., Dumont M., Cortez C., Glass J.D., Starkov A., Manfredi G. In Vivo pathogenic role of mutant SOD1 localized in the mitochondrial intermembrane space. J. Neurosci. 2011;31:15826&#x2013;15837. doi: 10.1523/JNEUROSCI.1965-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1965-11.2011</ArticleId><ArticleId IdType="pmc">PMC3249412</ArticleId><ArticleId IdType="pubmed">22049426</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattiazzi M., D&#x2019;Aurelio M., Gajewski C.D., Martushova K., Kiaei M., Flint Beal M., Manfredi G. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 2002;277:29626&#x2013;29633. doi: 10.1074/jbc.M203065200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M203065200</ArticleId><ArticleId IdType="pubmed">12050154</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayvergiya C., Beal M.F., Buck J., Manfredi G. Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. J. Neurosci. 2005;25:2463&#x2013;2470. doi: 10.1523/JNEUROSCI.4385-04.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4385-04.2005</ArticleId><ArticleId IdType="pmc">PMC6725162</ArticleId><ArticleId IdType="pubmed">15758154</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos K.J., Chapman A.L., Tennant M.E., Manser C., Tudor E.L., Lau K.-F., Brownlees J., Ackerley S., Shaw P.J., McLoughlin D.M., et al. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum. Mol. Genet. 2007;16:2720&#x2013;2728. doi: 10.1093/hmg/ddm226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm226</ArticleId><ArticleId IdType="pmc">PMC4516806</ArticleId><ArticleId IdType="pubmed">17725983</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins C.M.J., Jung C., Xu Z. ALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes. BMC Neurosci. 2003;4:16. doi: 10.1186/1471-2202-4-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-4-16</ArticleId><ArticleId IdType="pmc">PMC169170</ArticleId><ArticleId IdType="pubmed">12864925</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C., McDonald K.K., Boukhedimi Y., McAlonis-Downes M., Lobsiger C.S., Bel Hadj S., Zandona A., Julien J.-P., Shah S.B., Cleveland D.W. Misfolded SOD1 associated with motor neuron mitochondria alters mitochondrial shape and distribution prior to clinical onset. PLoS ONE. 2011;6:e22031. doi: 10.1371/journal.pone.0022031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022031</ArticleId><ArticleId IdType="pmc">PMC3136936</ArticleId><ArticleId IdType="pubmed">21779368</ArticleId></ArticleIdList></Reference><Reference><Citation>Karam C., Yi J., Xiao Y., Dhakal K., Zhang L., Li X., Manno C., Xu J., Li K., Cheng H., et al. Absence of physiological Ca2+ transients is an initial trigger for mitochondrial dysfunction in skeletal muscle following denervation. Skelet. Muscle. 2017;7:6. doi: 10.1186/s13395-017-0123-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13395-017-0123-0</ArticleId><ArticleId IdType="pmc">PMC5387329</ArticleId><ArticleId IdType="pubmed">28395670</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y., Karam C., Yi J., Zhang L., Li X., Yoon D., Wang H., Dhakal K., Ramlow P., Yu T., et al. ROS-related mitochondrial dysfunction in skeletal muscle of an ALS mouse model during the disease progression. Pharmacol. Res. 2018;138:25&#x2013;36. doi: 10.1016/j.phrs.2018.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2018.09.008</ArticleId><ArticleId IdType="pmc">PMC6263743</ArticleId><ArticleId IdType="pubmed">30236524</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi J., Ma C., Li Y., Weisleder N., R&#xed;os E., Ma J., Zhou J. Mitochondrial calcium uptake regulates rapid calcium transients in skeletal muscle during Excitation-Contraction (E-C) coupling. J. Biol. Chem. 2011;286:32436&#x2013;32443. doi: 10.1074/jbc.M110.217711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.217711</ArticleId><ArticleId IdType="pmc">PMC3173159</ArticleId><ArticleId IdType="pubmed">21795684</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Li A., Li X., Yi J. Dysregulated mitochondrial Ca2+ and ROS signaling in skeletal muscle of ALS mouse model. Arch. Biochem. Biophys. 2019;663:249&#x2013;258. doi: 10.1016/j.abb.2019.01.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2019.01.024</ArticleId><ArticleId IdType="pmc">PMC6506190</ArticleId><ArticleId IdType="pubmed">30682329</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Yi J., Fu R., Liu E., Siddique T., R&#xed;os E., Deng H.-X. Hyperactive intracellular calcium signaling associated with localized mitochondrial defects in skeletal muscle of an animal model of amyotrophic lateral sclerosis. J. Biol. Chem. 2010;285:705&#x2013;712. doi: 10.1074/jbc.M109.041319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.041319</ArticleId><ArticleId IdType="pmc">PMC2804218</ArticleId><ArticleId IdType="pubmed">19889637</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi J., Li A., Li X., Park K., Zhou X., Yi F., Xiao Y., Yoon D., Tan T., Ostrow L.W., et al. MG53 preserves neuromuscular junction integrity and alleviates ALS disease progression. Antioxidants. 2021;10:1522. doi: 10.3390/antiox10101522.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10101522</ArticleId><ArticleId IdType="pmc">PMC8532806</ArticleId><ArticleId IdType="pubmed">34679657</ArticleId></ArticleIdList></Reference><Reference><Citation>Donohoe D.R., Garge N., Zhang X., Sun W., O&#x2019;Connell T.M., Bunger M.K., Bultman S.J. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011;13:517&#x2013;526. doi: 10.1016/j.cmet.2011.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2011.02.018</ArticleId><ArticleId IdType="pmc">PMC3099420</ArticleId><ArticleId IdType="pubmed">21531334</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupton J.R. Microbial degradation products influence colon cancer risk: The butyrate controversy. J. Nutr. 2004;134:479&#x2013;482. doi: 10.1093/jn/134.2.479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/134.2.479</ArticleId><ArticleId IdType="pubmed">14747692</ArticleId></ArticleIdList></Reference><Reference><Citation>Canani R.B., Costanzo M.D., Leone L., Pedata M., Meli R., Calignano A. Potential beneficial effects of bu-tyrate in intestinal and extraintestinal diseases. World J Gastroenterol. 2011;17:1519&#x2013;1528. doi: 10.3748/wjg.v17.i12.1519.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v17.i12.1519</ArticleId><ArticleId IdType="pmc">PMC3070119</ArticleId><ArticleId IdType="pubmed">21472114</ArticleId></ArticleIdList></Reference><Reference><Citation>Krajmalnik-Brown R., Ilhan Z.-E., Kang D.-W., DiBaise J.K. Effects of gut microbes on nutrient absorption and energy regulation. Nutr. Clin. Pr. 2012;27:201&#x2013;214. doi: 10.1177/0884533611436116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0884533611436116</ArticleId><ArticleId IdType="pmc">PMC3601187</ArticleId><ArticleId IdType="pubmed">22367888</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Hara A.M., Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006;7:688&#x2013;693. doi: 10.1038/sj.embor.7400731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.embor.7400731</ArticleId><ArticleId IdType="pmc">PMC1500832</ArticleId><ArticleId IdType="pubmed">16819463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourassa M.W., Alim I., Bultman S.J., Ratan R.R. Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health? Neurosci. Lett. 2016;625:56&#x2013;63. doi: 10.1016/j.neulet.2016.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.02.009</ArticleId><ArticleId IdType="pmc">PMC4903954</ArticleId><ArticleId IdType="pubmed">26868600</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla S., Tekwani B.L. Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation. Front. Pharmacol. 2020;11:537. doi: 10.3389/fphar.2020.00537.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.00537</ArticleId><ArticleId IdType="pmc">PMC7194116</ArticleId><ArticleId IdType="pubmed">32390854</ArticleId></ArticleIdList></Reference><Reference><Citation>Li A., Li X., Yi J., Ma J., Zhou J. Butyrate feeding reverses CypD-related mitoflash phenotypes in mouse myofibers. Int. J. Mol. Sci. 2021;22:7412. doi: 10.3390/ijms22147412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22147412</ArticleId><ArticleId IdType="pmc">PMC8304904</ArticleId><ArticleId IdType="pubmed">34299032</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Marcos P.J., Auwerx J. Regulation of PGC-1&#x3b1;, a nodal regulator of mitochondrial biogenesis. Am. J. Clin. Nutr. 2011;93:884S&#x2013;890S. doi: 10.3945/ajcn.110.001917.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.110.001917</ArticleId><ArticleId IdType="pmc">PMC3057551</ArticleId><ArticleId IdType="pubmed">21289221</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarpulla R.C. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim. Biophys. Acta. 2011;1813:1269&#x2013;1278. doi: 10.1016/j.bbamcr.2010.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2010.09.019</ArticleId><ArticleId IdType="pmc">PMC3035754</ArticleId><ArticleId IdType="pubmed">20933024</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventura-Clapier R., Garnier A., Veksler V. Transcriptional control of mitochondrial biogenesis: The central role of PGC-1 alpha. Cardiovasc. Res. 2008;79:208&#x2013;217. doi: 10.1093/cvr/cvn098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvn098</ArticleId><ArticleId IdType="pubmed">18430751</ArticleId></ArticleIdList></Reference><Reference><Citation>Thau N., Knippenberg S., K&#xf6;rner S., Rath K.J., Dengler R., Petri S. Decreased mRNA expression of PGC-1&#x3b1; and PGC-1&#x3b1;-regulated factors in the SOD1G93AALS mouse model and in human sporadic ALS. J. Neuropathol. Exp. Neurol. 2012;71:1064&#x2013;1074. doi: 10.1097/NEN.0b013e318275df4b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318275df4b</ArticleId><ArticleId IdType="pubmed">23147503</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Varghese M., Yemul S., Pan Y., Cheng A., Marano P., Hassan S., Vempati P., Chen F., Qian X., et al. Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1&#x3b1;) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis. Mol. Neurodegener. 2011;6:51. doi: 10.1186/1750-1326-6-51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-51</ArticleId><ArticleId IdType="pmc">PMC3156746</ArticleId><ArticleId IdType="pubmed">21771318</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese M., Zhao W., Trageser K.J., Pasinetti G.M. Peroxisome Proliferator Activator Receptor Gamma Coactivator-1&#x3b1; Overexpression in Amyotrophic Lateral Sclerosis: A Tale of Two Transgenics. Biomolecules. 2020;10:760. doi: 10.3390/biom10050760.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10050760</ArticleId><ArticleId IdType="pmc">PMC7277592</ArticleId><ArticleId IdType="pubmed">32414179</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose S., Bennuri S.C., Davis J.E., Wynne R., Slattery J.C., Tippett M., Delhey L., Melnyk S., Kahler S.G., Macfabe D.F., et al. Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism. Transl. Psychiatry. 2018;8:42. doi: 10.1038/s41398-017-0089-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-017-0089-z</ArticleId><ArticleId IdType="pmc">PMC5804031</ArticleId><ArticleId IdType="pubmed">29391397</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Yu B., Yu J., Zheng P., Huang Z., Luo Y., Luo J., Mao X., Yan H., He J., et al. Butyrate promotes slow-twitch myofiber formation and mitochondrial biogenesis in finishing pigs via inducing specific microRNAs and PGC-1&#x3b1; expression1. J. Anim. Sci. 2019;97:3180&#x2013;3192. doi: 10.1093/jas/skz187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jas/skz187</ArticleId><ArticleId IdType="pmc">PMC6667260</ArticleId><ArticleId IdType="pubmed">31228349</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Yi J., Li X., Xiao Y., Dhakal K., Zhou J. ALS-associated mutation SOD1G93A leads to abnormal mitochondrial dynamics in osteocytes. Bone. 2018;106:126&#x2013;138. doi: 10.1016/j.bone.2017.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2017.10.010</ArticleId><ArticleId IdType="pmc">PMC5718158</ArticleId><ArticleId IdType="pubmed">29030231</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J., Hervias I., Henning M.S., Damiano M., Kawamata H., Manfredi G. Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities. Hum. Mol. Genet. 2009;18:4552&#x2013;4564. doi: 10.1093/hmg/ddp421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp421</ArticleId><ArticleId IdType="pmc">PMC2773270</ArticleId><ArticleId IdType="pubmed">19779023</ArticleId></ArticleIdList></Reference><Reference><Citation>Raimondi A., Mangolini A., Rizzardini M., Tartari S., Massari S., Bendotti C., Francolini M., Borgese N., Cantoni L., Pietrini G. Cell culture models to investigate the selective vulnerability of motoneuronal mitochondria to familial ALS-linked G93ASOD1. Eur. J. Neurosci. 2006;24:387&#x2013;399. doi: 10.1111/j.1460-9568.2006.04922.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2006.04922.x</ArticleId><ArticleId IdType="pubmed">16903849</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo G., Yi J., Ma C., Xiao Y., Yi F., Yu T., Zhou J. Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model. PLoS ONE. 2013;8:e82112. doi: 10.1371/journal.pone.0082112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0082112</ArticleId><ArticleId IdType="pmc">PMC3855744</ArticleId><ArticleId IdType="pubmed">24324755</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters S.G., Pomare E.W., Fisher C.A. Portal and peripheral blood short chain fatty acid concentrations after caecal lactulose instillation at surgery. Gut. 1992;33:1249&#x2013;1252. doi: 10.1136/gut.33.9.1249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.33.9.1249</ArticleId><ArticleId IdType="pmc">PMC1379496</ArticleId><ArticleId IdType="pubmed">1427380</ArticleId></ArticleIdList></Reference><Reference><Citation>Juanola O., Ferrusqu&#xed;a-Acosta J., Garc&#xed;a-Villalba R., Zapater P., Magaz M., Mar&#xed;n A., Olivas P., Baiges A., Bellot P., Turon F., et al. Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis. FASEB J. 2019;33:11595&#x2013;11605. doi: 10.1096/fj.201901327R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201901327R</ArticleId><ArticleId IdType="pubmed">31345057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R.X., Lee J.S., Campbell E., Colgan S.P. Microbiota-derived butyrate dynamically regulates intestinal homeostasis through regulation of actin-associated protein synaptopodin. Proc. Natl. Acad. Sci. USA. 2020;117:11648&#x2013;11657. doi: 10.1073/pnas.1917597117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1917597117</ArticleId><ArticleId IdType="pmc">PMC7260972</ArticleId><ArticleId IdType="pubmed">32398370</ArticleId></ArticleIdList></Reference><Reference><Citation>Biermann J., Boyle J., Pielen A., Lagr&#xe8;ze W.A. Histone deacetylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells. Mol. Vis. 2011;17:395&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3036563</ArticleId><ArticleId IdType="pubmed">21311741</ArticleId></ArticleIdList></Reference><Reference><Citation>Sefat N.A.K., Mohammadi M.M., Hadjati J., Talebi S., Ajami M., Daneshvar H. Sodium butyrate as a histone deacetylase inhibitor affects toll-like receptor 4 expression in colorectal cancer cell lines. Immunol. Investig. 2019;48:759&#x2013;769. doi: 10.1080/08820139.2019.1595643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08820139.2019.1595643</ArticleId><ArticleId IdType="pubmed">31117848</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Wu H., Fan M., Yu R., Zhang Y., Liu J., Zhou X., Cai Y., Huang S., Hu Z., et al. Sodium butyrate inhibits migration and induces AMPK-mTOR pathway-dependent autophagy and ROS-mediated apoptosis via the miR-139-5p/Bmi-1 axis in human bladder cancer cells. FASEB J. 2020;34:4266&#x2013;4282. doi: 10.1096/fj.201902626R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201902626R</ArticleId><ArticleId IdType="pubmed">31957111</ArticleId></ArticleIdList></Reference><Reference><Citation>Burger-van Paassen N., Vincent A., Puiman P.J., Van Der Sluis M., Bouma J., Boehm G., van Goudoever J.B., Van Seuningen I., Renes I.B. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: Implications for epithelial protection. Biochem. J. 2009;420:211&#x2013;219. doi: 10.1042/BJ20082222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20082222</ArticleId><ArticleId IdType="pubmed">19228118</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidwai F., Costea D.E., Hutchison I., Mackenzie I. The effects of CD44 down-regulation on stem cell properties of head and neck cancer cell lines. J. Oral Pathol. Med. 2013;42:682&#x2013;690. doi: 10.1111/jop.12076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jop.12076</ArticleId><ArticleId IdType="pubmed">23627635</ArticleId></ArticleIdList></Reference><Reference><Citation>Weaver E.M., Zamora F.J., Puplampu-Dove Y.A., Kiessu E., Hearne J.L., Martin-Caraballo M. Regulation of T-type calcium channel expression by sodium butyrate in prostate cancer cells. Eur. J. Pharmacol. 2015;749:20&#x2013;31. doi: 10.1016/j.ejphar.2014.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2014.12.021</ArticleId><ArticleId IdType="pubmed">25557765</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor M.A., Khathayer F., Ray S.K. Quercetin and sodium butyrate synergistically increase apoptosis in rat C6 and human T98G glioblastoma cells through inhibition of autophagy. Neurochem. Res. 2019;44:1715&#x2013;1725. doi: 10.1007/s11064-019-02802-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-019-02802-8</ArticleId><ArticleId IdType="pubmed">31011879</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamovich Y., Shlomai A., Tsvetkov P., Umansky K.B., Reuven N., Estall J., Spiegelman B.M., Shaul Y. The protein level of PGC-1&#x3b1;, a key metabolic regulator, is controlled by NADH-NQO1. Mol. Cell. Biol. 2013;33:2603&#x2013;2613. doi: 10.1128/MCB.01672-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01672-12</ArticleId><ArticleId IdType="pmc">PMC3700121</ArticleId><ArticleId IdType="pubmed">23648480</ArticleId></ArticleIdList></Reference><Reference><Citation>Molinari E., Gilman M., Natesan S. Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo. EMBO J. 1999;18:6439&#x2013;6447. doi: 10.1093/emboj/18.22.6439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/18.22.6439</ArticleId><ArticleId IdType="pmc">PMC1171706</ArticleId><ArticleId IdType="pubmed">10562555</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikas A., Jensen K., Patel A., Costello J., Reynolds S.M., Mendonca-Torres M.C., Thakur S., Klubo-Gwiezdzinska J., Ylli D., Wartofsky L., et al. Cytochrome C oxidase subunit 4 (COX4): A potential therapeutic target for the treatment of medullary thyroid cancer. Cancers. 2020;12:2548. doi: 10.3390/cancers12092548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12092548</ArticleId><ArticleId IdType="pmc">PMC7565757</ArticleId><ArticleId IdType="pubmed">32911610</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosler J.P., Ferguson-Miller S., Calhoun M.W., Thomas J.W., Hill J., Lemieux L., Ma J., Georgiou C., Fetter J., Shapleigh J. Insight into the active-site structure and function of cytochrome oxidase by analysis of site-directed mutants of bacterial cytochrome aa3 and cytochrome bo. J. Bioenerg. Biomembr. 1993;25:121&#x2013;136. doi: 10.1007/BF00762854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00762854</ArticleId><ArticleId IdType="pubmed">8389745</ArticleId></ArticleIdList></Reference><Reference><Citation>Napiwotzki J., Kadenbach B. Extramitochondrial ATP/ADP-ratios regulate cytochrome c oxidase activity via binding to the cytosolic domain of subunit IV. Biol. Chem. 1998;379:335&#x2013;340. doi: 10.1515/bchm.1998.379.3.335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/bchm.1998.379.3.335</ArticleId><ArticleId IdType="pubmed">9563830</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J., Cortez C., Gan W.-B., Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum. Mol. Genet. 2014;23:1413&#x2013;1424. doi: 10.1093/hmg/ddt528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt528</ArticleId><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermann B. Bioenergetic role of mitochondrial fusion and fission. Biochim. Biophys. Acta (BBA) Bioenerg. 2012;1817:1833&#x2013;1838. doi: 10.1016/j.bbabio.2012.02.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2012.02.033</ArticleId><ArticleId IdType="pubmed">22409868</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang H., Ward W.F. PGC-1&#x3b1;: A key regulator of energy metabolism. Adv. Physiol. Educ. 2006;30:145&#x2013;151. doi: 10.1152/advan.00052.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/advan.00052.2006</ArticleId><ArticleId IdType="pubmed">17108241</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z., Yin J., Zhang J., Ward R.E., Martin R.J., Lefevre M., Cefalu W.T., Ye J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes. 2009;58:1509&#x2013;1517. doi: 10.2337/db08-1637.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db08-1637</ArticleId><ArticleId IdType="pmc">PMC2699871</ArticleId><ArticleId IdType="pubmed">19366864</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Gao S., Jun G., Zhao R., Yang X. Supplementing the maternal diet of rats with butyrate enhances mitochondrial biogenesis in the skeletal muscles of weaned offspring. Br. J. Nutr. 2017;117:12&#x2013;20. doi: 10.1017/S0007114516004402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114516004402</ArticleId><ArticleId IdType="pubmed">28091351</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersson-Klein A., Izadi M., Ferreira D., Cervenka I., Correia J., Martinez-Redondo V., Southern M., Cameron M., Kamenecka T., Agudelo L., et al. Small molecule PGC-1&#x3b1;1 protein stabilizers induce adipocyte Ucp1 expression and uncoupled mitochondrial respiration. Mol. Metab. 2018;9:28&#x2013;42. doi: 10.1016/j.molmet.2018.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2018.01.017</ArticleId><ArticleId IdType="pmc">PMC5870114</ArticleId><ArticleId IdType="pubmed">29428596</ArticleId></ArticleIdList></Reference><Reference><Citation>Sano M., Tokudome S., Shimizu N., Yoshikawa N., Ogawa C., Shirakawa K., Endo J., Katayama T., Yuasa S., Ieda M., et al. Intramolecular control of protein stability, subnuclear compartmentalization, and coactivator function of peroxisome proliferator-activated receptor gamma coactivator 1 alpha. J. Biol. Chem. 2007;282:25970&#x2013;25980. doi: 10.1074/jbc.M703634200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M703634200</ArticleId><ArticleId IdType="pubmed">17620342</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold S. Cytochrome c oxidase and its role in neurodegeneration and neuroprotection. Adv. Exp. Med. Biol. 2012;748:305&#x2013;339. doi: 10.1007/978-1-4614-3573-0_13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4614-3573-0_13</ArticleId><ArticleId IdType="pubmed">22729864</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.F., Park J.S., Deng J.H., Bai Y.D. Cytochrome c oxidase subunit IV is essential for assembly and respir-atory function of the enzyme complex. J. Bioenerg. Biomembr. 2006;38:283&#x2013;291. doi: 10.1007/s10863-006-9052-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10863-006-9052-z</ArticleId><ArticleId IdType="pmc">PMC1885940</ArticleId><ArticleId IdType="pubmed">17091399</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominy J.E., Puigserver P. Mitochondrial biogenesis through activation of nuclear signaling proteins. Cold Spring Harb. Perspect. Biol. 2013;5:a015008. doi: 10.1101/cshperspect.a015008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a015008</ArticleId><ArticleId IdType="pmc">PMC3685894</ArticleId><ArticleId IdType="pubmed">23818499</ArticleId></ArticleIdList></Reference><Reference><Citation>Jornayvaz F.R., Shulman G.I. Regulation of mitochondrial biogenesis. Essays Biochem. 2010;47:69&#x2013;84. doi: 10.1042/bse0470069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bse0470069</ArticleId><ArticleId IdType="pmc">PMC3883043</ArticleId><ArticleId IdType="pubmed">20533901</ArticleId></ArticleIdList></Reference><Reference><Citation>Tovar-Y-Romo L.B., Santa-Cruz L.D., Tapia R. Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis. Mol. Neurodegener. 2009;4:31. doi: 10.1186/1750-1326-4-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-4-31</ArticleId><ArticleId IdType="pmc">PMC2720968</ArticleId><ArticleId IdType="pubmed">19619317</ArticleId></ArticleIdList></Reference><Reference><Citation>Astbury S.M., Corfe B.M. Uptake and metabolism of the short-chain fatty acid butyrate, a critical review of the literature. Curr. Drug Metab. 2012;13:815&#x2013;821. doi: 10.2174/138920012800840428.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920012800840428</ArticleId><ArticleId IdType="pubmed">22571479</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganapathy V., Thangaraju M., Prasad P.D., Martin P.M., Singh N. Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr. Opin. Pharmacol. 2013;13:869&#x2013;874. doi: 10.1016/j.coph.2013.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2013.08.006</ArticleId><ArticleId IdType="pubmed">23978504</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves P., Martel F. Butyrate and colorectal cancer: The role of butyrate transport. Curr. Drug Metab. 2013;14:994&#x2013;1008. doi: 10.2174/1389200211314090006.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389200211314090006</ArticleId><ArticleId IdType="pubmed">24160296</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivaprakasam S., Bhutia Y.D., Yang S., Ganapathy V. Short-chain fatty acid transporters: Role in colonic homeostasis. Compr. Physiol. 2017;8:299&#x2013;314. doi: 10.1002/cphy.c170014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c170014</ArticleId><ArticleId IdType="pmc">PMC6019286</ArticleId><ArticleId IdType="pubmed">29357130</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>